Pathogenesis of preeclampsia: Implications of apoptotic markers and oxidative stress

Human and Experimental Toxicology

Volumn 32, Issue 11, 2013, Pages 1170-1178

  Shaker, O G ^a   Sadik, N A H ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

apoptosis; caspases; DNA fragmentation; lipid peroxidation; MDA; Preeclampsia

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BIOLOGICAL MARKER; CASPASE 8; CASPASE 9; DNA FRAGMENT; FERROUS CHLORIDE; MALONALDEHYDE;

ADULT; APOPTOSIS; ARTICLE; BIRTH WEIGHT; CESAREAN SECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LIPID PEROXIDATION; MATERNAL AGE; OXIDATIVE STRESS; PATHOGENESIS; PLACENTA; PLACENTA WEIGHT; PREECLAMPSIA; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; VAGINAL DELIVERY;

APOPTOSIS; CASPASES; DNA FRAGMENTATION; LIPID PEROXIDATION; MDA; PREECLAMPSIA;

ADOLESCENT; ADULT; APOPTOSIS; CASPASE 8; CASPASE 9; DNA FRAGMENTATION; FEMALE; HUMANS; LIPID PEROXIDES; MALONDIALDEHYDE; OXIDATIVE STRESS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; URIC ACID; YOUNG ADULT;

EID: 84889075244     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327112472998     Document Type: Article

References (43)

1. Hung TH, Skepper JN, Charnock-Jones DS, Burton GJ. Hypoxia-reoxygenation: a potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia. Circ Res. 2002 ; 90: 1274-1281
2. Aban M, Cinel L, Arslan M, Dilek U, Kaplanoglu M, Arpaci R, et al. Expression of nuclear factor-Kappa B and placental apoptosis in pregnancies complicated with intrauterine growth restriction and preeclampsia: an immunohistochemical study. Tohoku J Exp Med. 2004 ; 204: 195-202
3. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and metaanalysis. BMJ. 2007 ;: 335 974
4. Magee LA, von Dadelszen P. Pre-eclampsia and increased cardiovascular risk. BMJ. 2007 ; 335: 945-946
5. Smith GN, Walker MC, Liu A, Wen SW, Swansburg M, Ramshaw H, et al. Pre-eclampsia new emerging team (PE-NET). A history of preeclampsia identifies women who have underlying cardiovascular risk factors. Am J Obstet Gynecol. 2009 ; 200 (1). 58.e1-58.e8
6. Chan PY, Morris JM, Leslie GI, Kelly PJ, Gallery ED. The long-term effects of prematurity and intrauterine growth restriction on cardiovascular, renal, and metabolic function. Int J Pediatr. 2010 ;: 280402
7. Pettit F, Brown MA. The management of pre-eclampsia: what we think we know. Eur J Obstet Gynecol Reprod Biol. 2012 ; 160 (1). 6-12
8. Myatt L, Cui X. Oxidative stress in the placenta. Histochem Cell Biol. 2004 ; 122 (4). 369-382
9. Walsh SW, Vaughan JE, Wang Y, Roberts LJ. Placental isoprostane is significantly increased in preeclampsia. FASEB J. 2000 ; 14 (10). 1289-1296
10. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature. 1980 ; 284 (5756). 555-556
11. Favaloro B, Allocati N, Graziano V, Di Ilio C, De Laurenzi V. Role of apoptosis in disease. Aging (Albany NY). 2012 ; (5). 330-349
12. Bainbridge SA, Sidle EH, Smith GN. Direct placental effects of cigarette smoke protect women from preeclampsia: the specific roles of carbon monoxide and antioxidant systems in the placenta. Med Hypotheses. 2005 ; 64: 17-27
13. Stegh AH, Peter ME. Apoptosis and caspases. Cardiol Clin. 2001 ; 19: 13-29
14. Stennicke HR, Salvesen GS. Properties of the caspases. Biochim Biophys Acta. 1998 ; 1387: 17-31
15. Chesley LC. Diagnosis of preeclampsia. Obstet Gynecol. 1985 ; 65 (3). 423-425
16. Livingston JC, Park V, Barton JR, Elfering S, Haddad E, Mabie WC, et al. Lack of association of severe preeclampsia with maternal and fetal mutant alleles for tumor necrosis factor α and lymphotoxin α genes and plasma tumor necrosis factor α levels. Am J Obstet Gynecol. 2001 ; 184 (6). 1273-1277
17. Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: malondialdehyde and 4-hydroxynonenal. Meth Enzymol. 1990 ; 186: 407-421
18. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 ; 72: 248-254
19. Buege JA, Aust SD. Microsomal lipid peroxidation. Meth Enzymol. 1987 ; 52: 302-310
20. Perandones CE, Illera VA, Peckham D, Stunz LL, Ashman RF. Regulation of apoptosis in vitro in mature murine spleen T cells. J Immunol. 1993 ; 151: 3521-3529
21. Fossati P, Prencipe L, Berti G. Use of 3,5-dichloro-2- hydroxybenzenesulfonic acid/4-aminophenazone chromogenic system in direct enzymatic assay of uric acid in serum and urine. Clin Chem. 1980 ; 26: 227-231
22. Diamant S, Kissilevitz R, Diamant Y. Lipid peroxidation in human placental tissue: general properties and influence of gestational age. Biol Reprod. 1980 ; 23: 776-781
23. Robak J, Sobanska B. Relationship between lipid peroxidation and prostaglandin generation in rabbit tissues. Biochem Pharmacol. 1976 ; 25: 2233-2236
24. Zhang Z, Blake DR, Stevens CR, Kanczler JM, Winyard PG, Symons MC, et al. A reappraisal of xanthine dehydrogenase and oxidase in hypoxic reperfusion injury: The role of NADH as an electron donor. Free Rad Res. 1998 ; 28: 151-164
25. Khaw KS, Wang CC, Nagn Kee WD, Pang CP, Rogers MS. Effects of high inspired oxygen fraction during elective cesarean section under spinal anesthesia on maternal and fetal oxygenation and lipid peroxidation. Br J Anaesth. 2002 ; 88: 18-23
26. Bainbridge SA, Roberts JM. Uric acid as a pathogenic factor in preeclampsia. Placenta. 2008 ; 29 ((Suppl. A)). S67 - S72
27. Koopmans CM, van Pampus MG, Groen H, Aarnoudse JG, van den Berg PP, Mol BW. Accuracy of serum uric acid as a predictive test for maternal complications in pre-eclampsia: bivariate meta-analysis and decision analysis. Eur J Obstet Gynecol Reprod Biol. 2009 ; 146: 8-14
28. Martin AC, Brown MA. Could uric acid have a pathogenic role in pre-eclampsia?. Nat Rev Nephrol. 2010 ; 6: 744-748
29. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, et al. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 1998 ; 17: 1675-1687
30. Wiktor H, Kankofer M, Schmerold I, Dadak A, Lopucki M, Niedermuller H. Oxidative DNA damage in placentas from normal and pre-eclamptic pregnancies. Virchows Arch. 2004 ; 445: 74-78
31. Jolly M, Sebire N, Harris J, Robinson S, Regan L. The risks associated with pregnancy in women aged 35 years or older. Hum Reprod. 2000 ; 15: 2433-2437
32. Petrovska S, Dejanova B, Jurisic V. Estrogens: Mechanisms of neuroprotective effects. J Physiol Biochem. 2012 ; 68 (3). 455-460
33. Yamada Z, Kitagwa M, Takemura T, Hirokawa K. Effect of maternal age on incidences of apoptotic and proliferative cells in trophoblasts of full-term human placenta. Mol Hum Reprod. 2001 ; 7: 1179-1185
34. Smith SC, Leung TN, Baker PN. Apoptosis is a rare event in the first trimester placental tissue. Am J Obstet Gynecol. 2001 ; 183: 697-699
35. Al-Mulhim AA, Abu-Heija A, Al-Jamma F, El-Harith EA. Preeclampsia: maternal risk factors and perinatal outcome. Fetal Diagn Ther. 2003 ; 18: 275-280
36. Wang X, Yi S, Athayde N, Trudinger B. Endothelial cell apoptosis is induced by fetal plasma from pregnancy with umbilical placental vascular disease. Am J Obstet Gynecol. 2002 ; 186: 557-563
37. Takehara Y, Yoshioka T, Sasaki J. Changes in the levels of lipoperoxide and antioxidant factors in human placenta during gestation. Acta Med Okayama. 1990 ; 44 (2). 103-111
38. Mu J, Kanzaki T, Si X, Tomimatsu T, Fukuda H, Shioji M, et al. Apoptosis and related proteins in placenta of intrauterine fetal death in prostaglandin F receptor-deficient mice. Biol Reprod. 2003 ; 68: 1968-1974
39. Hill CA, Fitch RH. Sex differences in mechanisms and outcome of neonatal hypoxia-ischemia in rodent models: implications for sex-specific neuroprotection in clinical neonatal practice. Neurol Res Int. 2012 ; 2012: 867531
40. Donders J, Hoffman NM. Gender differences in learning and memory after pediatric traumatic brain injury. Neuropsychology. 2002 ; 16 (4). 491-499
41. Raz S, Debastos AK, Newman JB, Batton D. Extreme prematurity and neuropsychological outcome in the preschool years. J Int Neuropsychol Soc. 2010 ; 16 (1). 169-179
42. Deveraux QL, Takahashi R, Salvesen GS, Reed JC. X-linked IAP is a direct inhibitor of cell-death proteases. Nature. 1997 ; (6639). 388 300-304
43. Carrel L, Willard HF. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature. 2005 ; 434 (7031). 400-404